Insider · CIK 0001535289
Johan M. Spoor
Files at CATX (Perspective Therapeutics, Inc.). First filing Nov 26, 2024, latest Apr 1, 2025.
In brief
Johan M. Spoor files SEC Form 4 as CEO and director at CATX (Perspective Therapeutics, Inc.). Since Nov 26, 2024, Johan M. Spoor has reported 3 open-market buys worth $190k and 0 open-market sells worth $0, the latest filed on Apr 1, 2025.
A track record needs three past buys with six months of prices behind them; Johan M. Spoor has 0, so none is measured yet.
The newest scored trade: bought $60k of CATX on Mar 28, 2025, filed Apr 1, 2025, scored 75 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CATX: Perspective Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 75Notable | Perspective Therapeutics, Inc. | $60k 26,676 shares | +71% | 0% from low-86% from high | |
| 56Moderate | Perspective Therapeutics, Inc. | $30k 8,000 shares | +28% | - | |
| 53Moderate | Perspective Therapeutics, Inc. | $100k 26,500 shares | +19% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +735,000 | $0.00 | $0 | 735,000 | Mar 4, 2026 |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +22,026 | $2.24 | $49k | 59,383 | Apr 1, 2025 |
| Mar 28, 2025 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Child #1 | +4,650 | $2.21 | $10k | 4,650 | Apr 1, 2025 |
| Dec 4, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +8,000 | $3.77 | $30k | 36,257 | Dec 4, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stock | +14,500 | $3.78 | $55k | 152,072 | Nov 26, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By IRA of Reporting Owner | +5,400 | $3.80 | $21k | 5,400 | Nov 26, 2024 |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By IRA of Spouse | +6,600 | $3.80 | $25k | 66,600 | Nov 26, 2024 |
Questions about Johan M. Spoor
Answered from the filings on this page, as of the latest one.
Is Johan M. Spoor buying or selling?
Not in the last 12 months. Johan M. Spoor's latest open-market trade on SEC Form 4 was bought $60k of CATX on Mar 28, 2025.
How did Johan M. Spoor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Johan M. Spoor has 0.
Where does Johan M. Spoor file Form 4?
Johan M. Spoor has filed Form 4 at CATX (Perspective Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.